IL138035A0 - Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivative - Google Patents

Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivative

Info

Publication number: IL138035A0
Authority: IL; Israel
Prior art keywords: derivative; composition containing; synergistic combination; antitumor composition; anthracycline
Prior art date: 1998-03-24

Application number

IL13803599A

Other languages

English (en)

Original Assignee

Pharmacia & Upjohn Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-24

Filing date

1999-03-19

Publication date

2001-10-31

1999-03-19 Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa

2001-10-31 Publication of IL138035A0 publication Critical patent/IL138035A0/xx

Links

229940045799 anthracyclines and related substance Drugs 0.000 title 1
230000000259 anti-tumor effect Effects 0.000 title 1
VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical class C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 title 1
239000000203 mixture Substances 0.000 title 1
239000011885 synergistic combination Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IL13803599A 1998-03-24 1999-03-19 Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivative IL138035A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9806324.1A GB9806324D0 (en)	1998-03-24	1998-03-24	Antitumour synergetic composition
PCT/EP1999/001897 WO1999048503A1 (en)	1998-03-24	1999-03-19	Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate

Publications (1)

Publication Number	Publication Date
IL138035A0 true IL138035A0 (en)	2001-10-31

Family

ID=10829188

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL13803599A IL138035A0 (en)	1998-03-24	1999-03-19	Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivative

Country Status (29)

Country	Link
US (1)	US6403563B1 (cs)
EP (1)	EP1067941B1 (cs)
JP (1)	JP2002507571A (cs)
KR (1)	KR20010034619A (cs)
CN (2)	CN1528334A (cs)
AR (1)	AR018166A1 (cs)
AT (1)	ATE271388T1 (cs)
AU (1)	AU758191B2 (cs)
BR (1)	BR9908391A (cs)
CA (1)	CA2324610A1 (cs)
CZ (1)	CZ295368B6 (cs)
DE (1)	DE69918819T2 (cs)
DK (1)	DK1067941T3 (cs)
EA (1)	EA003134B1 (cs)
ES (1)	ES2226366T3 (cs)
GB (1)	GB9806324D0 (cs)
HU (1)	HUP0101615A3 (cs)
ID (1)	ID26091A (cs)
IL (1)	IL138035A0 (cs)
MY (1)	MY133016A (cs)
NO (1)	NO20004703D0 (cs)
NZ (1)	NZ507570A (cs)
PL (1)	PL343098A1 (cs)
PT (1)	PT1067941E (cs)
SI (1)	SI1067941T1 (cs)
TW (1)	TW576740B (cs)
UA (1)	UA63000C2 (cs)
WO (1)	WO1999048503A1 (cs)
ZA (1)	ZA992255B (cs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6820065B1 (en) *	1998-03-18	2004-11-16	Ascom Hasler Mailing Systems Inc.	System and method for management of postage meter licenses
GB9904387D0 (en) *	1999-02-25	1999-04-21	Pharmacia & Upjohn Spa	Antitumour synergistic composition
GB9909925D0 (en) *	1999-04-29	1999-06-30	Pharmacia & Upjohn Spa	Combined preparations comprising anthracycline derivatives
GB9916882D0 (en) *	1999-07-19	1999-09-22	Pharmacia & Upjohn Spa	Antitumor synergistic composition
GB9926843D0 (en) *	1999-11-12	2000-01-12	Pharmacia & Upjohn Spa	Lipid complex of alkycyclines
US6627614B1 (en) *	2002-06-05	2003-09-30	Super Gen, Inc.	Sequential therapy comprising a 20(S)-camptothecin and an anthracycline
EP1985286A1 (en) *	2007-04-24	2008-10-29	Biocompatibles UK Limited	Microspheres for treatment of brain tumours
US20090107925A1 (en) *	2007-10-31	2009-04-30	Chevron U.S.A. Inc.	Apparatus and process for treating an aqueous solution containing biological contaminants
US8349764B2 (en)	2007-10-31	2013-01-08	Molycorp Minerals, Llc	Composition for treating a fluid
US20110207760A1 (en) *	2010-02-23	2011-08-25	Valery Alakhov	Sn-38 compositions
DK3012329T3 (da)	2010-06-18	2017-11-20	Myriad Genetics Inc	Fremgangsmåder og materialer til at vurdere tab af heterozygositet
DK2609216T3 (en)	2010-08-24	2016-09-12	Dana Farber Cancer Inst Inc	Methods to predict anti-cancer response
US9233863B2 (en)	2011-04-13	2016-01-12	Molycorp Minerals, Llc	Rare earth removal of hydrated and hydroxyl species
EP3693473B1 (en)	2011-06-17	2025-02-19	Myriad Genetics, Inc.	Methods and materials for assessing allelic imbalance
BR112014015152A2 (pt)	2011-12-21	2017-07-04	Myriad Genetics Inc	métodos e materiais para a avaliação da perda de heterozigosidade
DK3415915T3 (da)	2012-02-23	2024-11-04	Childrens Medical Center	Fremgangsmåde til at forudsige respons til PARP-inhibitorer
AU2013273466B2 (en)	2012-06-07	2018-11-01	Inserm (Institut National De La Sante Et De La Recherche Medicale)	Methods for detecting inactivation of the homologous recombination pathway (BRCA1/2) in human tumors
WO2014160080A1 (en)	2013-03-14	2014-10-02	Children's Medical Center Corporation	Cancer diagnosis, treatment selection and treatment
DK2981624T3 (da)	2013-04-05	2020-03-02	Myriad Genetics Inc	Fremgangsmåder til vurdering af homolog rekombinationsdeficiens og forudsigelse af respons på cancerbehandling
WO2015086473A1 (en)	2013-12-09	2015-06-18	Institut Curie	Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
MX370462B (es)	2014-03-07	2019-12-13	Secure Natural Resources Llc	Oxido de cerio (iv) con propiedades de remocion de arsenico excepcionales.
ES2946251T3 (es)	2014-08-15	2023-07-14	Myriad Genetics Inc	Métodos y materiales para evaluar la deficiencia de recombinación homóloga
EP4141127B1 (en)	2021-08-30	2024-10-09	Zentrum Familiärer Brust- und Eierstockkrebs Universitätsklinik Köln	Method for assessing homologous recombination deficiency in ovarian cancer cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9114549D0 (en) *	1991-07-05	1991-08-21	Erba Carlo Spa	Mono and bis alkylamino-anthracyclines
GB9325417D0 (en) *	1993-12-13	1994-02-16	Erba Carlo Spa	3'- aziridino-anthracycline derivatives

1998
- 1998-03-24 GB GBGB9806324.1A patent/GB9806324D0/en not_active Ceased
1999
- 1999-02-25 TW TW088102834A patent/TW576740B/zh not_active IP Right Cessation
- 1999-03-19 JP JP2000537551A patent/JP2002507571A/ja not_active Withdrawn
- 1999-03-19 ES ES99914528T patent/ES2226366T3/es not_active Expired - Lifetime
- 1999-03-19 AU AU33314/99A patent/AU758191B2/en not_active Ceased
- 1999-03-19 IL IL13803599A patent/IL138035A0/xx unknown
- 1999-03-19 DE DE69918819T patent/DE69918819T2/de not_active Expired - Fee Related
- 1999-03-19 SI SI9930675T patent/SI1067941T1/xx unknown
- 1999-03-19 UA UA2000105982A patent/UA63000C2/uk unknown
- 1999-03-19 BR BR9908391-4A patent/BR9908391A/pt not_active IP Right Cessation
- 1999-03-19 CA CA002324610A patent/CA2324610A1/en not_active Abandoned
- 1999-03-19 NZ NZ507570A patent/NZ507570A/xx unknown
- 1999-03-19 DK DK99914528T patent/DK1067941T3/da active
- 1999-03-19 ID IDW20001882A patent/ID26091A/id unknown
- 1999-03-19 CN CNA2004100317041A patent/CN1528334A/zh active Pending
- 1999-03-19 HU HU0101615A patent/HUP0101615A3/hu unknown
- 1999-03-19 PT PT99914528T patent/PT1067941E/pt unknown
- 1999-03-19 CN CNB998043141A patent/CN1150002C/zh not_active Expired - Fee Related
- 1999-03-19 AT AT99914528T patent/ATE271388T1/de not_active IP Right Cessation
- 1999-03-19 PL PL99343098A patent/PL343098A1/xx unknown
- 1999-03-19 EA EA200000978A patent/EA003134B1/ru not_active IP Right Cessation
- 1999-03-19 US US09/646,096 patent/US6403563B1/en not_active Expired - Fee Related
- 1999-03-19 KR KR1020007010503A patent/KR20010034619A/ko not_active Ceased
- 1999-03-19 CZ CZ20003493A patent/CZ295368B6/cs not_active IP Right Cessation
- 1999-03-19 EP EP99914528A patent/EP1067941B1/en not_active Expired - Lifetime
- 1999-03-19 WO PCT/EP1999/001897 patent/WO1999048503A1/en not_active Ceased
- 1999-03-22 AR ARP990101246A patent/AR018166A1/es unknown
- 1999-03-22 MY MYPI99001071A patent/MY133016A/en unknown
- 1999-03-23 ZA ZA9902255A patent/ZA992255B/xx unknown
2000
- 2000-09-20 NO NO20004703A patent/NO20004703D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
SI1067941T1 (en)	2005-02-28
UA63000C2 (en)	2004-01-15
NO20004703L (no)	2000-09-20
WO1999048503A1 (en)	1999-09-30
EA003134B1 (ru)	2003-02-27
DE69918819D1 (de)	2004-08-26
CA2324610A1 (en)	1999-09-30
NO20004703D0 (no)	2000-09-20
ZA992255B (en)	1999-10-05
PT1067941E (pt)	2004-12-31
PL343098A1 (en)	2001-07-30
CN1528334A (zh)	2004-09-15
KR20010034619A (ko)	2001-04-25
HUP0101615A2 (hu)	2001-10-28
AU758191B2 (en)	2003-03-20
EP1067941A1 (en)	2001-01-17
AR018166A1 (es)	2001-10-31
NZ507570A (en)	2003-01-31
EA200000978A1 (ru)	2001-02-26
EP1067941B1 (en)	2004-07-21
DK1067941T3 (da)	2004-11-29
HUP0101615A3 (en)	2002-12-28
ES2226366T3 (es)	2005-03-16
GB9806324D0 (en)	1998-05-20
CN1150002C (zh)	2004-05-19
CZ295368B6 (cs)	2005-07-13
CZ20003493A3 (cs)	2001-02-14
ID26091A (id)	2000-11-23
JP2002507571A (ja)	2002-03-12
US6403563B1 (en)	2002-06-11
CN1294516A (zh)	2001-05-09
ATE271388T1 (de)	2004-08-15
BR9908391A (pt)	2000-10-31
AU3331499A (en)	1999-10-18
MY133016A (en)	2007-10-31
DE69918819T2 (de)	2005-08-18
TW576740B (en)	2004-02-21

Publication	Publication Date	Title
HUP0101615A3 (en)	2002-12-28	Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate
SG75160A1 (en)	2000-09-19	Compounds with protected hydroxy groups
GB9904387D0 (en)	1999-04-21	Antitumour synergistic composition
EG20753A (en)	2000-01-31	Synergistic composition
EG23999A (en)	2008-03-19	Camptothecin derivatives having antitumor activity
IL148806A0 (en)	2002-09-12	C-aryl glucoside derivatives and pharmaceutical compositions containing the same
IL143703A0 (en)	2002-04-21	Fibre blend for enteral composition
AU4548899A (en)	1999-12-20	Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents
NZ512210A (en)	2004-12-24	Camptothecin analogs useful for treating cancer and leukemia
AU4168899A (en)	2000-01-05	Benzanilide derivatives and medicinal compositions
EP1109552A4 (en)	2007-11-07	NOVEL ANTICANCING AGENTS GENERATING DNA CLEAVAGE
GB2296495B (en)	1998-04-15	Anthracycline derivatives
ZA982863B (en)	1998-10-08	Synergistic fungicadal composition
IL134592A0 (en)	2001-04-30	Compositions comprising camptothecin compounds for the treatment of cancer with reduced side effects
GB9802041D0 (en)	1998-03-25	Complexing compositions
HUP0102520A3 (en)	2003-04-28	Sweetener compositions
GB9513551D0 (en)	1995-09-06	Anti-bacterial synergistic composition
IL115819A0 (en)	1996-01-19	Substituted tetracyclic azepine derivatives
PL353770A1 (en)	2003-12-01	Streptomyces avermitilis
PL353874A1 (en)	2003-12-01	Streptomyces avermitilis
AP9901525A0 (en)	1999-06-30	2"-Deoxy hydromycin derivatives
GB9727546D0 (en)	1998-03-18	Anthracycline glycosides
GB9904386D0 (en)	1999-04-21	Antitumour synergistic composition
GB9800047D0 (en)	1998-03-04	Anthracycline glycosides
GB9828883D0 (en)	1999-02-17	New cytotoxic pyridoacridine alcaloids